Texas Biomed Receives $5 Million Grant to Study Potential Functional Cure for Babies Born with HIV
Thursday, December 3, 2015 - 11:10
in Health & Medicine
The National Institutes of Health have awarded scientists at Texas Biomedical Research Institute and collaborators at the Food and Drug Administration, UCLA and the University of Pennsylvania a $5 million grant over the next 4 years to study a combination antiviral drugs and investigative AIDS vaccines aimed at treating infants and children affected by HIV. Dr. Ruth Ruprecht, Scientist & Director of the Texas Biomed AIDS Research Program, is leading this study.